Viridian Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $27.20 on 11/12/24, and the lowest price during the same period was recorded at $11.40 on 06/04/24.
52-week price history of VRDN Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Viridian Therapeutics Inc’s current trading price is -29.60% away from its 52-week high, while its distance from the 52-week low is 67.98%. The stock’s price range during this period has fluctuated between $11.40 and $27.20. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.25 million for the day, which was evidently lower than the average daily volume of 1.29 million over the last three months.
Financial Performance and Market Capitalization
Viridian Therapeutics Inc (VRDN) has experienced a quarterly decline of -18.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.52B and boasts a workforce of 96 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 20.53, with a change in price of +4.23. Similarly, Viridian Therapeutics Inc recorded 1,498,833 in trading volume during the last 100 days, posting a change of +28.35%.
VRDN Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VRDN stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
VRDN Stock Stochastic Average
The raw stochastic average for Viridian Therapeutics Inc over the last 50 days is presently at 20.61%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 31.71%. Further, the company’s Stochastic %K and %D values for the last 20 days were 45.27% and 46.84%, respectively.
VRDN Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -0.10% this year. Over the last six months, there has been a weaker performance of 56.07%. The price of VRDN leaped by -2.89% during the last 30 days period. For the last 5-days stocks have slided -0.10%.
